Dog genetic testing versus cancer testing: what’s the difference?

Start with the question the test is designed to answer

Two tests can both analyse DNA while answering very different questions. A genetic health result is not automatically a cancer result, and a cancer-related blood test is not a complete genetic health assessment.

Genetic health testing

Many genetic tests look for inherited DNA variants associated with particular traits or conditions. A result may help a veterinarian interpret risk or plan care, but its meaning depends on the variant, condition and individual animal. Different panels cover different variants; they do not capture every possible health risk. UC Davis: What genetic testing can and can’t tell you about your pet.

Cancer-related testing

Cancer evaluation addresses a current clinical question: whether a dog may have cancer, what kind it is, how far it has spread, or how it is responding to treatment. The workup may involve cell or tissue examination, imaging and other tests. DNA-based liquid biopsy is one area of investigation; a particular test’s evidence and intended use matter. AAHA: Tumor diagnostics and staging and CANDiD liquid-biopsy validation study.

Where an epigenetic baseline fits

Epigenetic marks help describe how cells use DNA. Canos Origin combines a genetic health report with a stored epigenetic baseline from a blood draw. That baseline is a reference for future comparisons and research. Origin does not tell you that your dog is cancer-free and is not a cancer screening test.

For a dog already diagnosed with cancer, OncoTrack is a separate exploratory monitoring trial. Your dog’s veterinarian remains responsible for clinical assessment and treatment decisions.

Before ordering

Ask what is measured, which question the result can answer, what it cannot exclude, and who will explain it. Choose the test around your dog’s needs, rather than the word “DNA” on its own.